Brief Report: Increased Frequency of CD39+ CD56bright Natural Killer Cells in HIV-1 Infection Correlates With Immune Activation and Disease Progression-Reference-Cited by-同舟云学术

Brief Report: Increased Frequency of CD39+ CD56bright Natural Killer Cells in HIV-1 Infection Correlates With Immune Activation and Disease Progression

Published:2017-04-01 Issue:4 Volume:74 Page:467-472
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Dierks Patrick,Wroblewski Raluca,Eberhard Johanna M.,Martrus Gloria,Degen Olaf,Hertling Sandra,Schmiedel Stefan,Lunemann Sebastian,Hüfner Anja,Lohse Ansgar W.,Altfeld Marcus,van Lunzen Jan,Schulze zur Wiesch Julian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference32 articles.

1. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis;Moretta;Annu Rev Immunol.,2001

2. Control of human viral infections by natural killer cells;Jost;Annu Rev Immunol.,2013

3. NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection;Alter;J Intern Med.,2009

4. NK cells in HIV disease;Scully;Curr HIV/AIDS Rep.,2016

5. Changes in natural killer cell activation and function during primary HIV-1 Infection;Naranbhai;PLoS One,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?;Frontiers in Immunology;2023-10-19

2. The Role of Cluster of Differentiation 39 (CD39) and Purinergic Signaling Pathway in Viral Infections;Pathogens;2023-02-08

3. CD38+CD39+ NK cells associate with HIV disease progression and negatively regulate T cell proliferation;Frontiers in Immunology;2022-10-04

4. High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4+ T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19;Viruses;2022-06-10

5. Exploring the Utility of NK Cells in COVID-19;Biomedicines;2022-04-26